Industry News
-
ModeX Therapeutics to Present Preclinical Data on In Vivo CAR-T Generation Using LNP/mRNA Platform
May 12 2026 -
Fractyl Health Receives European Authorization to Begin First-in-Human Trial of AAV-Based GLP-1 Gene Therapy
May 11 2026 -
Spur Therapeutics Reports New AAV Gene Therapy Data Showing Potential Bone Health Benefits in Gaucher Disease Type 1
May 08 2026 -
Beacon Therapeutics Reports 12-Month AAV Gene Therapy Benefit in X-Linked Retinitis Pigmentosa
May 08 2026 -
Atsena Reports Durable AAV Gene Therapy Data in XLRS and LCA1 at ARVO 2026
May 07 2026 -
Opus Genetics Completes Enrollment in Cohort 1 of OPGx-BEST1 Gene Therapy Study for BEST Disease
May 07 2026 -
REYON and Elligene Report 52-Week AAV Gene Therapy NG101 Data in Wet AMD
May 07 2026 -
Apertura Gene Therapy and TSC Alliance Collaborate to Advance AAV Gene Therapy Programs for Tuberous Sclerosis Complex
May 06 2026 -
Valerio Therapeutics Launches InVimmune to Advance In Vivo Cell Therapy
May 05 2026